Cargando…

206 Studying AKI in COVID-19 Patients in the ICU using Nephrocheck Biomarker

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973167/ http://dx.doi.org/10.1053/j.ajkd.2021.02.211

Ejemplares similares

NephroCheck at 10: addressing unmet needs in AKI diagnosis and risk stratification
por: Martin-Cleary, Catalina, et al.
Publicado: (2023)

Sepsis and AKI in ICU Patients: The Role of Plasma Biomarkers
por: Lentini, Paolo, et al.
Publicado: (2012)

NephroCheck: should we consider urine osmolality?
por: Noto, Alberto, et al.
Publicado: (2019)

Unsupervised clustering reveals phenotypes of AKI in ICU COVID-19 patients
por: Legouis, David, et al.
Publicado: (2022)

Evaluating Nephrocheck(®) as a Predictive Tool for Acute Kidney Injury
por: Nalesso, Federico, et al.
Publicado: (2020)

POS-206 INCIDENCE AND EARLY PREDICTORS OF AKI IN COVID 19 PATIENTS IN A TERTIARY CARE CENTRE : A RETROSPECTIVE STUDY
por: R, B., et al.
Publicado: (2021)

Biomarkers for early diagnosis of AKI in the ICU: ready for prime time use at the bedside?
por: Honore, Patrick M, et al.
Publicado: (2012)

NephroCheck data compared to serum creatinine in various clinical settings
por: Pajenda, Sahra, et al.
Publicado: (2015)

Erratum: Unsupervised clustering reveals phenotypes of AKI in ICU COVID-19 patients
Publicado: (2023)

Prediction Models for AKI in ICU: A Comparative Study
por: Qian, Qing, et al.
Publicado: (2021)

Impact of diuretics use over AKI development and hospital mortality in ICU patients
por: Banderas-Bravo, E, et al.
Publicado: (2015)

Serum Creatinine Levels and Nephrocheck® Values With and Without Correction for Urine Dilution-A Multicenter Observational Study
por: Hahn, Robert G., et al.
Publicado: (2022)

Timing of dialysis initiation in AKI in ICU: international survey
por: Thakar, Charuhas V, et al.
Publicado: (2012)

Significant microalbuminuria, on admission to the ICU, may indicate AKI in patients with sepsis
por: Basu, S, et al.
Publicado: (2010)

Advances in the study of subclinical AKI biomarkers
por: Zou, Chenchen, et al.
Publicado: (2022)

POS-870 NGAL and microalbuminuria as AKi biomarkers in COVID-19 hospitalized patients with pneumonia
por: Rizo Topete MD, L., et al.
Publicado: (2022)

Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score
por: Palomba, Henrique, et al.
Publicado: (2023)

The NephroCheck bedside system for detecting stage 3 acute kidney injury after open thoracoabdominal aortic repair
por: Doukas, Panagiotis, et al.
Publicado: (2023)

Subclinical AKI is still AKI
por: Ronco, Claudio, et al.
Publicado: (2012)

The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck(®) parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment
por: Knafl, Daniela, et al.
Publicado: (2017)

AKI patients have worse long-term outcomes, especially in the immediate post-ICU period
por: Hoste, Eric AJ, et al.
Publicado: (2012)

ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
por: Truche, A. S., et al.
Publicado: (2018)

First Post-Operative Urinary Kidney Injury Biomarkers and Association with the Duration of AKI in the TRIBE-AKI Cohort
por: Coca, Steven G., et al.
Publicado: (2016)

Cost-effectiveness and value of information analysis of NephroCheck and NGAL tests compared to standard care for the diagnosis of acute kidney injury
por: Jacobsen, Elisabet, et al.
Publicado: (2021)

Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study
por: Liu, Kathleen D., et al.
Publicado: (2016)

NOT AN ALL OUT FAILURE: RRT IN AKI IN PATIENTS WITH COVID-19
por: GRANT-SITTOL, JANEEN, et al.
Publicado: (2021)

Trajectory of AKI and hospital mortality among patients with COVID-19
por: Kim, Seong Geun, et al.
Publicado: (2023)

206. The Utility of Lactate as a Biomarker for Sepsis in Cancer Patients
por: Mathew, Suji, et al.
Publicado: (2020)

Neonatal AKI profile using KDIGO guidelines: A cohort study in tertiary care hospital ICU of Lahore, Pakistan
por: Gul, Rafia, et al.
Publicado: (2022)

Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels
por: Matsuura, Ryo, et al.
Publicado: (2018)

Cross-sectional survey on adult acute kidney injury in Chinese ICU: the study protocol (CARE-AKI)
por: Yang, Zhenyu, et al.
Publicado: (2018)

Investigation of AKI with Early Biomarkers After Cardiac Surgery
por: Mutlu, Hüseyin, et al.
Publicado: (2020)

34 Outcome Comparison in Hospitalized COVID-19 Patients With and Without AKI
Publicado: (2023)

Association between triglyceride-glucose index and AKI in ICU patients based on MIMICIV database: a cross-sectional study
por: Jin, Zihan, et al.
Publicado: (2023)

IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI
por: Li, Hai-Lun, et al.
Publicado: (2018)

Significance of platelets in the early warning of new-onset AKI in the ICU by using supervise learning: a retrospective analysis
por: Pan, Pan, et al.
Publicado: (2023)

Is urine microscopy a useful early biomarker for cardiac surgeryrelated AKI?
por: Perazella, Mark A.
Publicado: (2020)

Health Canada: AKI or ARF with remdesivir for COVID-19?
Publicado: (2021)

COVID-19 and AKI: Where Do We Stand?
por: Palevsky, Paul M.
Publicado: (2021)

The measurement of basal creatinine and the diagnosis of AKI with COVID-19
por: Kuong-Guitton, Edward, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jl3omoijsa97paq7qjjkp8ts3l